tirzepatide + nad Molecular structure of and the dual activation mechanism of I’ll never deny it #tirzepatide

At 28 weeks, berobenatide demonstrated dose-dependent decreases in A1C up to 2.2% and in body weight of up to 10.2% with a slope that continued to decrease weekly, said Ildiko Lingvay, MD, MPH, MSCS, Professor in the Department of Internal Medicine, University of Texas Southwestern Medical Center

2014 Feb;13(1):8-12

Notably, around 30% of solid organ transplant recipients experience post-transplant diabetes[1]

There is a big role for health tech in facilitating this transition

The decision to use these medications should consider reproductive timeline, with those planning near-term pregnancy potentially benefiting from alternative weight loss strategies

Others who should avoid taking it are children under age 18 and women who are pregnant or nursing